New research indicates that genetic factors play a more significant role in human longevity than previously estimated, with findings suggesting that genetics account for approximately 50% of lifespan when non-aging-related causes of death are excluded. This revised perspective could accelerate the development of targeted drugs and treatments aimed at slowing the aging process.
The study, led by Uri Alon, director of the Sagol Institute for Longevity Research at the Weizmann Institute of Science in Israel, explored the impact of genes on lifespan by modeling scenarios where deaths from accidents, infections, and other external factors were removed from the equation. The results, published in early 2026, highlight a substantial genetic influence on how long individuals live.
Alon, a systems biologist with a background in physics, noted that aging is the primary risk factor for major age-related diseases, including cancer, dementia, metabolic disorders, and heart disease. By slowing the rate of aging through targeted interventions, he suggests, it may be possible to achieve preventative medicine for a wide range of conditions simultaneously.
Despite the emphasis on genetic influence, Alon stressed that lifestyle factors such as exercise, diet, and sleep remain crucial. "You need that in order for our genes to express themselves in their optimal way," he stated. He continues to maintain a healthy lifestyle himself, swimming and eating salads, underscoring the interplay between genetics and environment.
The findings offer a strong incentive for further research into the genetics of aging, potentially leading to novel therapeutic strategies that could extend healthy human lifespans. The research was featured in Time magazine's focus on longevity leaders.